Blood Transfusion Diagnostics Market: By Technology (ELISA, Nucleic Acid Amplification, Rapid Test, Real-Time PCR, Fluorescence Assay, and Western Blot), By Product Type (Platelets, Red Blood Cells, and Albumin), By Application (Disease Screening, Blood Grouping, Others), By End User (Hospitals, Blood Banks, Diagnostic Laboratories), and By Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Blood Transfusion Diagnostics Market was valued at $4.49 billion in 2022 and is anticipated to grow at $7.09 billion till 2029 recording a CAGR of 7.1% during the forecast period 2023-2029. Blood transfusion is a medical procedure in which the blood is donated to the patient through a narrow tube that is placed within the vein. The blood transfusion is a life-saving procedure which helps in replacing the blood loss during surgery or injury. The transfusion process is done even if the patient's body is not capable of make blood owing to illness. With blood transfusion process, blood products like red blood cells, white blood cells, platelets and others are transfused to the patient. The blood transfusion diagnostics play a vital role in the blood transfusion which reduces the chance of infection. In June 2017, Grifols has launched Erytra Eflexis, the latest advancement in scalable blood typing solutions which can adapt to different laboratory workflow. Blood transfusion is the intravenous transfer of blood or blood products. Blood transfusions can be used to replace blood components that have been lost. The most common blood components transfused include red blood cells, white blood cells, platelets, clotting factors, and plasma. During an emergency or a serious case of massive blood loss, these blood components are crucial to laboratories and hospitals. When haemoglobin levels fall below 100g/L, RBC transfusion is required. Before being transfused, blood from a donor must be checked for a variety of infectious diseases. As a result, blood transfusion diagnostics play a vital role in preventing infection in both the recipient and the healthcare workers.

Blood Transfusion Diagnostics Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

7.1%

Largest Market

North America

Fastest Growing Market

Asia-Pacific
Blood Transfusion Diagnostics Market Dynamics

The development in the technology is a key factor attributing to the growth of the blood transfusion diagnostics market. The growing blood transfusion procedures and increasing prevalence of infectious diseases are anticipated to drive the growth of the market. Increase in the awareness among the healthcare fraternity regarding the blood transfusion is likely to propel the growth of the market. The automation of the blood banks are adding fuel for the growth of the blood transfusion diagnostics market. However, the risk involved in the transmission of the infectious diseases is likely to hinder the growth of the blood transfusion diagnostics market.

Key Features of the Reports

  • The blood transfusion diagnostics market report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Blood Transfusion Diagnostics Market Segmentation

By Technology
  • ELISA
  • Nucleic Acid Amplification
  • Rapid Test
  • Real-Time PCR
  • Fluorescence Assay
  • Western Blot
By Product Type
  • Platelets
  • Red Blood Cells
  • Albumin
By Application
  • Disease Screening
  • Blood Grouping
  • Others
By End User
  • Hospitals
  • Blood Banks
  • Diagnostic Laboratories

Frequently Asked Questions

The Blood Transfusion Diagnostics Market size was valued at USD 4.49 billion in 2022

The Blood Transfusion Diagnostics Market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

Asia Pacific is the fastest-growing for Blood Transfusion Diagnostics Market

1.Executive Summary
2.Global Blood Transfusion Diagnostics Market Introduction 
2.1.Global Blood Transfusion Diagnostics Market  - Taxonomy
2.2.Global Blood Transfusion Diagnostics Market  - Definitions
2.2.1.Technology
2.2.2.Product Type
2.2.3.Application
2.2.4.End User
2.2.5.Region
3.Global Blood Transfusion Diagnostics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Blood Transfusion Diagnostics Market Analysis, 2018-2022 and Forecast 2023-2029
4.1.  Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Blood Transfusion Diagnostics Market By Technology, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. ELISA
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Nucleic Acid Amplification
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Rapid Test
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Real-Time PCR
5.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Fluorescence Assay
5.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Western Blot
5.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
6.Global Blood Transfusion Diagnostics Market By Product Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. Platelets
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Red Blood Cells
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Albumin
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7.Global Blood Transfusion Diagnostics Market By Application, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. Disease Screening
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Blood Grouping
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Others
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8.Global Blood Transfusion Diagnostics Market By End User, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. Hospitals
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Blood Banks
8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Diagnostic Laboratories
8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
9.Global Blood Transfusion Diagnostics Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10.North America Blood Transfusion Diagnostics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
10.1. Technology Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.ELISA
10.1.2.Nucleic Acid Amplification
10.1.3.Rapid Test
10.1.4.Real-Time PCR
10.1.5.Fluorescence Assay
10.1.6.Western Blot
10.2.  Product Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Platelets
10.2.2.Red Blood Cells
10.2.3.Albumin
10.3.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Disease Screening
10.3.2.Blood Grouping
10.3.3.Others
10.4.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Hospitals
10.4.2.Blood Banks
10.4.3.Diagnostic Laboratories
10.5.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11.Europe Blood Transfusion Diagnostics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
11.1. Technology Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.ELISA
11.1.2.Nucleic Acid Amplification
11.1.3.Rapid Test
11.1.4.Real-Time PCR
11.1.5.Fluorescence Assay
11.1.6.Western Blot
11.2.  Product Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Platelets
11.2.2.Red Blood Cells
11.2.3.Albumin
11.3.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Disease Screening
11.3.2.Blood Grouping
11.3.3.Others
11.4.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Hospitals
11.4.2.Blood Banks
11.4.3.Diagnostic Laboratories
11.5.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
11.5.6.Rest of EU
12.Asia Pacific (APAC) Blood Transfusion Diagnostics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
12.1. Technology Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.ELISA
12.1.2.Nucleic Acid Amplification
12.1.3.Rapid Test
12.1.4.Real-Time PCR
12.1.5.Fluorescence Assay
12.1.6.Western Blot
12.2.  Product Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Platelets
12.2.2.Red Blood Cells
12.2.3.Albumin
12.3.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Disease Screening
12.3.2.Blood Grouping
12.3.3.Others
12.4.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Hospitals
12.4.2.Blood Banks
12.4.3.Diagnostic Laboratories
12.5.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13.Middle East and Africa (MEA) Blood Transfusion Diagnostics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
13.1. Technology Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.ELISA
13.1.2.Nucleic Acid Amplification
13.1.3.Rapid Test
13.1.4.Real-Time PCR
13.1.5.Fluorescence Assay
13.1.6.Western Blot
13.2.  Product Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Platelets
13.2.2.Red Blood Cells
13.2.3.Albumin
13.3.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Disease Screening
13.3.2.Blood Grouping
13.3.3.Others
13.4.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Hospitals
13.4.2.Blood Banks
13.4.3.Diagnostic Laboratories
13.5.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14.Latin America Blood Transfusion Diagnostics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
14.1. Technology Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.ELISA
14.1.2.Nucleic Acid Amplification
14.1.3.Rapid Test
14.1.4.Real-Time PCR
14.1.5.Fluorescence Assay
14.1.6.Western Blot
14.2.  Product Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Platelets
14.2.2.Red Blood Cells
14.2.3.Albumin
14.3.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Disease Screening
14.3.2.Blood Grouping
14.3.3.Others
14.4.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Hospitals
14.4.2.Blood Banks
14.4.3.Diagnostic Laboratories
14.5.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Abbott Diagnostics (U.S)
15.2.2.Novartis AG (Switzerland)
15.2.3.Becton Dickinson (U.S)
15.2.4.BAG healthcare (Germany)
15.2.5.DiaSorin (Italy)
15.2.6.Fujirebio (Belgium)
15.2.7.Grifols (Spain)
15.2.8.Siemens (Germany)
15.2.9.Quidel (U.S)
15.2.10.Hologic/Gen-Probe (U.S)
15.2.11.Biokit (Spain)
15.2.12.Bio-Rad (U.S)
15.2.13.Beckman Coulter (U.S)
15.2.14.Quotient Limited (U.S)
15.2.15.Diagast (France)
16. Research Methodology 
17. Appendix and Abbreviations 
  • Abbott Diagnostics (U.S)
  • Novartis AG (Switzerland)
  • Becton Dickinson (U.S)
  • BAG healthcare (Germany)
  • DiaSorin (Italy)
  • Fujirebio (Belgium)
  • Grifols (Spain)
  • Siemens (Germany)
  • Quidel (U.S)
  • Hologic/Gen-Probe (U.S)
  • Biokit (Spain)
  • Bio-Rad (U.S)
  • Beckman Coulter (U.S)
  • Quotient Limited (U.S)
  • Diagast (France)

Adjacent Markets